Positivity (>1%) to IGF2BP3 was detected in 74 out of 83 patients (89%; Figure 1B–D), while the proportion of positively stained leukemia cells ranged from 1 to 100% (median 34%). The gene discussed is IGF2BP3; the disease is leukemia.